卡培他滨联合长春瑞滨新辅助化疗30例局部晚期乳腺癌疗效观察  被引量:2

The curative effect of capecitabine compound with vinorelbine treated 30 samples locally advanced breast cancer for neoadjuvant chemotherapy

在线阅读下载全文

作  者:姜专基[1] 张斌明[1] 杨碎胜[1] 宋波[1] 

机构地区:[1]甘肃省肿瘤医院乳腺科,甘肃兰州730050

出  处:《甘肃医药》2013年第3期188-190,共3页Gansu Medical Journal

摘  要:目的:探讨卡培他滨联合长春瑞滨新辅助化疗应用于LABC患者的疗效。方法:回顾性分析30例局部晚期乳腺癌患者进行新辅助化疗的临床资料,30例患者手术前均进行NX方案化疗4周期。结果:新辅助化疗客观有效率为90.00%(27/30),其中完全缓解16.67%(5/30),临床获益率为100.00%(30/30)。结论:新辅助化疗能使局部晚期乳腺癌原发灶和腋窝淋巴结缩小,肿瘤降期,减少肿瘤的远处转移和复发,改善患者预后,其临床毒副反应可以耐受。Objective: To explore the effect of capecitabine compound with vinorelbinc treated locally advanced breast cancer for neoadjuvant chemotherapy (NAC). Methods: To retrospectively analyze the clinical data of 30 locally advanced breast cancer patients who have conducted the NAC. All 30 patients received four cycles of scheme NX for NAC. Results: The objective rate of NAC is 90.00%(27/30), the complete reserve rate is16.67%(5/30); the clinical benefical rate of neoadjuvant chemotherapy is 100.00%(30/30). Conclusion: NAC enable primary focus and axillary nodes of the locally advanced breast cancer to shrink,downstage,reduce the risk of displacement and recurrence,its side-effect can be endured easily.

关 键 词:局部晚期乳腺癌 新辅助化疗 

分 类 号:R737.9[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象